Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy
Authors:
- A. KolbAKA. Kolb
- K-M. DebatinKDK-M. Debatin
- I. HerrIHI. Herr
- 1 October 2006
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 242 (1) , 104-111
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Interference of glucocorticoids with apoptosis signaling and host-tumor interactions.Cancer Biology & Therapy, 2004
- Systemic therapy for advanced hepatocellular carcinoma: a reviewEuropean Journal of Cancer, 2004
- New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric CancersThe Oncologist, 2004
- Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial CellsCancer Research, 2004
- Phase I/II Study of Hepatic Arterial Therapy With Floxuridine and Dexamethasone in Combination With Intravenous Irinotecan As Adjuvant Treatment After Resection of Hepatic Metastases From Colorectal CancerJournal of Clinical Oncology, 2003
- Effects of corticosteroid use on treatment of solid tumoursThe Lancet, 2002
- Glucocorticoid Receptor-mediated Protection from Apoptosis Is Associated with Induction of the Serine/Threonine Survival Kinase Gene, sgk-1Journal of Biological Chemistry, 2001
- Dexamethasone-Induced Enhancement of Resistance to Ionizing Radiation and Chemotherapeutic Agents in Human Tumor CellsStrahlentherapie und Onkologie, 1999
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Dexamethasone Stimulation of Metallothionein Synthesis in HeLa Cell CulturesScience, 1979